There were 1,754 press releases posted in the last 24 hours and 403,050 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Avotres Announces Achieving Primary Endpoint of its Phase 1/2 Clinical Trial of AVT001 in Patients with Type 1 Diabetes

TO:
Emmie Fan
Avotres Inc.
+1 973-487-6972

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image